title: Brain-Derived Neurotrophic Factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis.
abstract: BACKGROUND
  Brain-Derived Neurotrophic Factor (BDNF) is a neurotrophin that is involved in the synaptic plasticity and survival of neurons. BDNF is believed to be involved in the pathogenesis of several neuropsychiatric disorders. As findings of BDNF levels in anxiety disorders have been inconsistent, we undertook to conduct a systematic review and meta-analysis of studies that assessed BDNF protein levels in these disorders.
  
  
  METHODS
  We conducted the review using electronic databases and searched reference lists of relevant articles for any further studies. Studies that measured BDNF protein levels in any anxiety disorder and compared these to a control group were included. Effect sizes of the differences in BDNF levels between anxiety disorder and control groups were calculated.
  
  
  RESULTS
  Eight studies with a total of 1179 participants were included. Initial findings suggested that BDNF levels were lower in individuals with any anxiety disorder compared to those without [Standard Mean Difference (SMD) = -0.94 (-1.75, -0.12), p ≤ 0.05]. This was, however, dependent on source of BDNF protein [plasma: SMD = -1.31 (-1.69, -0.92), p ≤ 0.01; serum: SMD = -1.06 (-2.27, 0.16), p ≥ 0.01] and type of anxiety disorder [PTSD: SMD = -0.05 (-1.66, 1.75), p ≥ 0.01; OCD: SMD = -2.33 (-4.21, -0.45), p ≤ 0.01].
  
  
  CONCLUSIONS
  Although BDNF levels appear to be reduced in individuals with an anxiety disorder, this is not consistent across the various anxiety disorders and may largely be explained by the significantly lowered BDNF levels found in OCD. RESULTS further appear to be mediated by differences in sampling methods. Findings are, however, limited by the lack of research in this area, and given the potential for BDNF as a biomarker of anxiety disorders, it would be useful to clarify the relationship further.
authors.affiliation: MRC Anxiety Disorders Unit, Department of Psychiatry, Faculty of Medicine and Health Sciences, University of Stellenbosch Cape Town, South Africa.
authors.forename: Sharain
authors.initials: S
authors.lastname: Suliman
authors.forename: Sian M J
authors.initials: SM
authors.lastname: Hemmings
authors.forename: Soraya
authors.initials: S
authors.lastname: Seedat
keywords: BDNF; anxiety; meta-regression; protein; systematic review
references.citation: Biol Psychiatry. 2007 Jan 15;61(2):187-97
references.pmid: 16697351
references.citation: Psychiatry Res. 1998 Feb 27;77(3):167-74
references.pmid: 9707299
references.citation: Pharmacopsychiatry. 2009 Nov;42(6):270-6
references.pmid: 19924587
references.citation: Biol Psychiatry. 2008 Sep 15;64(6):527-32
references.pmid: 18571629
references.citation: Biol Psychiatry. 2007 Sep 1;62(5):530-5
references.pmid: 17560556
references.citation: Trends Neurosci. 1994 May;17(5):182-90
references.pmid: 7520198
references.citation: J Affect Disord. 2010 Apr;122(1-2):174-8
references.pmid: 19664825
references.citation: J Trauma Stress. 1995 Jan;8(1):75-90
references.pmid: 7712061
references.citation: Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13208-13
references.pmid: 16924103
references.citation: Depress Anxiety. 1997;5(3):127-9
references.pmid: 9323452
references.citation: Biol Psychiatry. 2008 Aug 15;64(4):281-5
references.pmid: 18406398
references.citation: Neuron. 2009 May 28;62(4):479-93
references.pmid: 19477151
references.citation: J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
references.pmid: 9881538
references.citation: Neurosci Lett. 2002 Aug 16;328(3):261-4
references.pmid: 12147321
references.citation: Brain Res Bull. 2007 Jun 15;73(1-3):143-9
references.pmid: 17499648
references.citation: Psychoneuroendocrinology. 2004 Nov;29(10):1281-9
references.pmid: 15288707
references.citation: World J Biol Psychiatry. 2010 Sep;11(6):763-73
references.pmid: 20334574
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2012 Sep;159B(6):731-40
references.pmid: 22815222
references.citation: Biol Psychiatry. 2003 Apr 15;53(8):707-42
references.pmid: 12706957
references.citation: World J Biol Psychiatry. 2008;9(2):126-34
references.pmid: 17853300
references.citation: Br J Psychiatry. 1991 Nov;159:645-53, 658
references.pmid: 1756340
references.citation: J Neurosci. 1990 Nov;10(11):3469-78
references.pmid: 2230938
references.citation: J Psychopharmacol. 2004 Jun;18(2):194-9
references.pmid: 15260907
references.citation: J Neurosci Methods. 2010 Mar 15;187(1):73-7
references.pmid: 20043947
references.citation: PLoS One. 2012;7(6):e39212
references.pmid: 22761741
references.citation: J Psychiatr Res. 2009 Jan;43(3):247-54
references.pmid: 18511076
references.citation: Biol Psychiatry. 2008 May 1;63(9):840-6
references.pmid: 17949690
references.citation: Neurobiol Aging. 2007 Sep;28(9):1436-45
references.pmid: 16879899
references.citation: Arch Gen Psychiatry. 1995 May;52(5):374-83
references.pmid: 7726718
references.citation: J Psychiatr Res. 2009 Sep;43(14):1175-84
references.pmid: 19376528
references.citation: Mol Psychiatry. 2002;7 Suppl 1:S29-34
references.pmid: 11986993
references.citation: Arch Gen Psychiatry. 1989 Nov;46(11):1006-11
references.pmid: 2684084
references.citation: Psychiatry Clin Neurosci. 2006 Jun;60(3):389-93
references.pmid: 16732759
references.citation: J Neurosci. 1995 Mar;15(3 Pt 1):1768-77
references.pmid: 7891134
references.citation: Biol Psychiatry. 2006 Jun 15;59(12):1116-27
references.pmid: 16631126
references.citation: Psychiatry Clin Neurosci. 2010 Aug;64(4):341-57
references.pmid: 20653908
references.citation: Mol Psychiatry. 2011 Nov;16(11):1088-95
references.pmid: 20856249
references.citation: Psychiatry Res. 2002 Mar 15;109(2):143-8
references.pmid: 11927139
references.citation: Psychoneuroendocrinology. 2011 Feb;36(2):228-39
references.pmid: 20702043
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun;29(5):658-63
references.pmid: 15905010
references.citation: Brain Res Bull. 2010 Jan 15;81(1):61-5
references.pmid: 19589373
references.citation: Nat Rev Neurosci. 2005 Aug;6(8):603-14
references.pmid: 16062169
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):459-62
references.pmid: 20097247
references.citation: EMBO J. 2001 Nov 1;20(21):5887-97
references.pmid: 11689429
references.citation: Neuropharmacology. 1998 Dec;37(12):1553-61
references.pmid: 9886678
references.citation: J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
references.pmid: 14399272
references.citation: Mol Psychiatry. 2014 Mar;19(3):281-3
references.pmid: 23670489
references.citation: J Affect Disord. 2011 Sep;133(1-2):305-10
references.pmid: 21616543
references.citation: Science. 2006 Oct 6;314(5796):140-3
references.pmid: 17023662
references.citation: J Clin Psychiatry. 2011 Aug;72(8):1124-8
references.pmid: 21208596
references.citation: Int Clin Psychopharmacol. 1995 Jun;10(2):83-93
references.pmid: 7673660
references.citation: Science. 2004 Oct 15;306(5695):487-91
references.pmid: 15486301
references.citation: Psychosom Med. 1979 May;41(3):209-18
references.pmid: 472086
references.citation: Biomarkers. 2012 Sep;17(6):524-31
references.pmid: 22672085
references.citation: Int J Neuropsychopharmacol. 2008 Dec;11(8):1169-80
references.pmid: 18752720
references.citation: Braz J Psychiatry. 2009 Mar;31(1):48-51
references.pmid: 19506776
references.citation: Bipolar Disord. 2007 Jun;9 Suppl 1:128-35
references.pmid: 17543031
references.citation: Prog Brain Res. 2001;133:287-302
references.pmid: 11589138
references.citation: PLoS One. 2009;4(5):e5424
references.pmid: 19412541
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1256-60
references.pmid: 16647794
references.citation: Arch Intern Med. 1993 Sep 27;153(18):2093-101
references.pmid: 8379800
references.citation: Alcohol. 2012 May;46(3):253-9
references.pmid: 22364688
references.citation: Exp Physiol. 2009 Oct;94(10):1062-9
references.pmid: 19666694
references.citation: Int J Neuropsychopharmacol. 2011 Apr;14(3):347-53
references.pmid: 20604989
references.citation: Protein Expr Purif. 1995 Aug;6(4):465-71
references.pmid: 8527932
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):415-20
references.pmid: 20732374
references.citation: Neuropsychopharmacology. 2007 Dec;32(12):2543-51
references.pmid: 17375136
references.citation: Psychoneuroendocrinology. 2010 Apr;35(3):364-8
references.pmid: 19682803
references.citation: J Affect Disord. 2008 Jan;105(1-3):279-83
references.pmid: 17553570
references.citation: Neuropsychopharmacology. 2002 Aug;27(2):133-42
references.pmid: 12093587
references.citation: N Engl J Med. 1998 Jan 15;338(3):171-9
references.pmid: 9428819
references.citation: Arch Gen Psychiatry. 1992 Sep;49(9):716-22
references.pmid: 1514877
references.citation: Biol Psychiatry. 2005 May 1;57(9):1068-72
references.pmid: 15860348
references.citation: Neuroscience. 2013 Jun 3;239:295-303
references.pmid: 23211562
references.citation: CNS Spectr. 2011 Sep;16(9):179-89
references.pmid: 24725632
references.citation: Brain Res. 1996 Feb 12;709(1):122-301
references.pmid: 8869564
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 1;33(5):899-902
references.pmid: 19409951
references.citation: Biol Psychiatry. 2008 Mar 15;63(6):619-28
references.pmid: 17884018
references.citation: World J Biol Psychiatry. 2012 Oct;13(7):535-43
references.pmid: 21888560
references.citation: Neurobiol Aging. 2005 Jan;26(1):115-23
references.pmid: 15585351
references.citation: Psychiatry Res. 1990 Oct;34(1):99-106
references.pmid: 2267266